Chapter Member Anniversaries: June 2018

Posted by ISPE Boston
On July 5, 2018

Please congratulate the following members celebrating milestone anniversaries in June 2018. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Keith A. Farnsworth, Zajac LLC Warren A. Hill Timothy J. Horgan, Alnylam Pharmaceuticals David L. Hyde, CBA, CPIP, Lantheus Medical Imaging, Inc. Richard G. Kotosky, PE, CPIP, […]

Welcome New Members!

Posted by ISPE Boston
On July 5, 2018

We would like to introduce the members who joined ISPE in June 2018, welcome them to the Chapter and encourage them (and all of our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And […]

Kaleido Biosciences Raises $101 Million to Develop Microbiome Therapies

Posted by ISPE Boston
On June 28, 2018

Bedford-based Kaleido Biosciences, a clinical-stage healthcare company developing novel chemistries to drive functions of the microbiome organ, has raised $101 million in an oversubscribed Series C financing. Kaleido plans to use the proceeds from this financing to advance its pipeline, including conducting multiple clinical studies across several therapeutic areas, and to expand its platform. “We […]

WuXi Biologics Chooses Worcester for First U.S. Manufacturing Facility

Posted by ISPE Boston
On June 21, 2018

WuXi Biologics of Shanghai has announced that it plans to invest $60 million and hire approximately 150 employees to establish a state-of-the-art biologics clinical and commercial manufacturing facility in Worcester. The Worcester facility will be WuXi Biologics’ first overseas site in the U.S. WuXi Biologics is a leading global platform company providing end-to-end solutions for […]

Sage Announces Results of FDA Breakthrough Therapy Meeting

Posted by ISPE Boston
On June 21, 2018

Sage Therapeutics has announced its expedited development plan for SAGE-217 following a Breakthrough Therapy meeting with the FDA. This development plan is intended to support a potential filing for approval of SAGE-217 in the U.S. for the treatment of major depressive disorder (MDD) and postpartum depression (PPD). “Sage is excited to receive feedback from the […]

Explore Medical Device Advances at MDG Conference June 25

Posted by ISPE Boston
On June 14, 2018

Join the Medical Development Group (MDG) for their June 25th program where presenters will provide overviews on how medical devices are contributing to many of the most important medical technology advances now changing health care. Medical devices are an innovative, essential, and rapidly evolving component of healthcare technology and delivery. This meeting will provide an […]

Student Development Committee Needs Your Help to Reach the Next Level

Posted by ISPE Boston
On June 14, 2018

We are thrilled to announce that George West from Albireo Energy will be joining the Student Development Committee. George will be phasing into the committee leadership role over the next 6-12 months as Brian Hagopian and Paige Kane phase into “less active but still involved” roles with the committee. George brings a wealth of management […]

Take Beer Making into Your Own Hands at Barleycorn’s Craft Beers

Posted by ISPE Boston
On June 12, 2018

There’s on old saying: “Do what you love and you’ll never work a day in your life.” Well, Tom Wilber, co-owner at Barleycorn’s Craft Brew is taking that to heart. Tom left the world of finance to take over Barleycorn’s, a craft brew facility in Natick, MA where people come together to brew their own […]

BIO Presents Henri A. Termeer Biotechnology Visionary Award

Posted by ISPE Boston
On June 7, 2018

The Biotechnology Innovation Organization (BIO) has announced the establishment of the Henri A. Termeer Biotechnology Visionary Award – created in honor of the late Genzyme CEO who was instrumental in transforming Boston into a thriving hub of life science research, development and innovation. The award was presented yesterday in Boston at the 2018 BIO International Convention to Dr. Sue […]

NIH Partners with Biopharma to Advance Cancer Immunotherapy

Posted by ISPE Boston
On June 7, 2018

In October 2017, the NIH and 11 leading biopharmaceutical companies launched PACT (the Partnership for Accelerating Cancer Therapies), a five-year public-private research collaboration totaling $215 million as part of the Cancer Moonshot. PACT will initially focus on efforts to identify, develop and validate robust biomarkers — standardized biological markers of disease and treatment response — […]

Page 81 of 90«‹79 808182 83 ›»